Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome

被引:55
作者
Frijns, CJM
Fijnheer, R
Algra, A
van Mourik, JA
van Gijn, J
Rinkel, GJE
机构
[1] Univ Med Ctr, Dept Neurol, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr, Dept Haematol, Res Lab, NL-3508 GA Utrecht, Netherlands
[3] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Sanquin Res CLB, Dept Plasma Prot, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1136/jnnp.2005.064956
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the relation of endothelial cell activation with delayed cerebral ischaemia (DCI) and outcome after subarachnoid haemorrhage (SAH). Methods: Concentrations of soluble (s) intercellular adhesion molecule-1, sE-selectin, sP-selectin, ED1-fibronectin, von Willebrand Factor (vWf), and vWf propeptide were measured within three days of SAH onset. The associations with poor outcome were investigated at three months in 106 patients. In 90 patients in whom the occurrence of cerebral ischaemia could be dated accurately, two analyses were undertaken: one for all ischaemic events (n = 32), including those related to treatment, and another for spontaneous DCI ( n = 11). Concentrations of markers were dichotomised at their medians. The associations of endothelial cell activation markers with outcome were expressed as odds ratios ( OR) from logistic regression and those with ischaemic events as hazard ratios (HR) derived from Cox regression. Results: Early vWf concentrations were associated with poor outcome ( crude OR = 4.6 (95% CI, 2.0 to 10.9; adjusted OR = 3.3 (1.1 to 9.8). Early levels of vWf were also positively related to occurrence of all ischaemic events ( crude HR = 2.3 ( 1.1 to 4.9); adjusted HR = 1.8 ( 0.8 to 3.9) and with occurrence of spontaneous DCI ( crude HR = 3.5 (0.9 to 13.1); adjusted HR = 2.2 (0.5 to 9.8). None of the other markers showed any associations. Conclusions: Concentrations of sICAM-1, sP-selectin, sE- selectin, and ED1-fibronectin do not predict the occurrence of DCI or outcome. The positive associations of raised early vWf concentrations with ischaemic events and poor outcome after SAH may reflect a predisposition to further ischaemic injury through formation of microthrombi in the cerebral circulation.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 30 条
[1]   Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage [J].
Aihara, Y ;
Kasuya, H ;
Onda, H ;
Hori, T ;
Takeda, J .
STROKE, 2001, 32 (01) :212-217
[2]   INTEROBSERVER AGREEMENT FOR THE ASSESSMENT OF HANDICAP IN STROKE PATIENTS [J].
BAMFORD, JM ;
SANDERCOCK, PAG ;
WARLOW, CP ;
SLATTERY, J .
STROKE, 1989, 20 (06) :828-828
[3]   Inflammatory mediators and stroke: New opportunities for novel therapeutics [J].
Barone, FC ;
Feuerstein, GZ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (08) :819-834
[4]   Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits [J].
Bavbek, M ;
Polin, R ;
Kwan, AL ;
Arthur, AS ;
Kassell, NF ;
Lee, KS .
STROKE, 1998, 29 (09) :1930-1935
[5]  
Beuth W, 2001, Neurol Neurochir Pol, V35 Suppl 5, P130
[6]   VASOSPASM DIAGNOSIS - THEORETICAL AND REAL TRANSCRANIAL DOPPLER SENSITIVITY [J].
CREISSARD, P ;
PROUST, F ;
LANGLOIS, O .
ACTA NEUROCHIRURGICA, 1995, 136 (3-4) :181-185
[7]  
DRAKE CG, 1988, J NEUROSURG, V68, P985
[8]   Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation [J].
Dumont, AS ;
Dumont, RJ ;
Chow, MM ;
Lin, CL ;
Calisaneller, T ;
Ley, KF ;
Kassell, NF ;
Lee, KS .
NEUROSURGERY, 2003, 53 (01) :123-133
[9]  
Fijnheer R, 1997, THROMB HAEMOSTASIS, V77, P1081
[10]   Endothelial cell activation after subarachnoid hemorrhage [J].
Frijns, CJM ;
Rinkel, GJE ;
Castigliego, D ;
van Gijn, J ;
Sixma, JJ ;
Fijnheer, R .
NEUROSURGERY, 2002, 50 (06) :1223-1229